Ileal sodium/bile acid cotransporter explained

Ileal sodium/bile acid cotransporter, also known as apical sodium–bile acid transporter (ASBT) and ileal bile acid transporter (IBAT), is a protein that in humans is encoded by the SLC10A2 gene.[1] [2]

ASBT/IBAT is most highly expressed in the ileum, where it is found on the brush border membrane of enterocytes. It is responsible for the initial uptake of bile acids, particularly conjugated bile acids, from the intestine as part of their enterohepatic circulation.[3]

As a drug target

Several medications to inhibit IBAT are under development. They include elobixibat, under development for the treatment of constipation and irritable bowel syndrome,[4] and volixibat, under development for the treatment of nonalcoholic steatohepatitis.

See also

References

Further reading

Notes and References

  1. Wong MH, Rao PN, Pettenati MJ, Dawson PA . Localization of the ileal sodium-bile acid cotransporter gene (SLC10A2) to human chromosome 13q33 . Genomics . 33 . 3 . 538–40 . May 1996 . 8661017 . 10.1006/geno.1996.0233 .
  2. Web site: Entrez Gene: SLC10A2 solute carrier family 10 (sodium/bile acid cotransporter family), member 2.
  3. Book: Dawson PA . Role of the Intestinal Bile Acid Transporters in Bile Acid and Drug Disposition . Drug Transporters . Handbook of Experimental Pharmacology . 201 . 169–203 . 2011 . 201 . 21103970 . 3249407 . 10.1007/978-3-642-14541-4_4 . 978-3-642-14540-7 .
  4. Acosta A, Camilleri M . Elobixibat and its potential role in chronic idiopathic constipation . Therapeutic Advances in Gastroenterology . 7 . 4 . 167–75 . July 2014 . 25057297 . 4107709 . 10.1177/1756283X14528269 .